A

Albireo Pharma Inc
F:BDQM

Watchlist Manager
Albireo Pharma Inc
F:BDQM
Watchlist
Price: 41.41 EUR 0.46%
Market Cap: 857.2m EUR

Relative Value

There is not enough data to reliably calculate the relative value of BDQM.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

BDQM Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
vs Industry
Median 3Y
16.2
Median 5Y
16.2
Industry
7.9
Forward
18.3
vs History
vs Industry
Median 3Y
-7.1
Median 5Y
-7.1
Industry
23.7
Forward
-8
vs History
vs Industry
Median 3Y
-8.1
Median 5Y
-7.9
Industry
22
vs History
vs Industry
Median 3Y
-7.3
Median 5Y
-7.3
Industry
23.8
vs History
vs Industry
Median 3Y
9.3
Median 5Y
9.1
Industry
3.3
vs History
vs Industry
Median 3Y
12.3
Median 5Y
12.4
Industry
8.3
Forward
14.2
vs History
vs Industry
Median 3Y
12.9
Median 5Y
12.6
Industry
10.1
vs History
vs Industry
Median 3Y
-5.8
Median 5Y
-5.6
Industry
6.4
vs History
vs Industry
Median 3Y
-5.8
Median 5Y
-5.6
Industry
7
vs History
vs Industry
Median 3Y
-6.1
Median 5Y
-5.9
Industry
8.3
vs History
vs Industry
Median 3Y
-6.1
Median 5Y
-5.9
Industry
6.5
vs History
vs Industry
Median 3Y
7.7
Median 5Y
7.7
Industry
5.7

Multiples Across Competitors

BDQM Competitors Multiples
Albireo Pharma Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Albireo Pharma Inc
F:BDQM
856.9m EUR 17.5 -7.7 -6.4 -6.4
FR
Pharnext SCA
OTC:PNEXF
6T USD 33 809 907.8 -160 693.5 -195 133.1 -192 906.4
US
Abbvie Inc
NYSE:ABBV
394.7B USD 6.6 168.1 16.3 23.1
US
Amgen Inc
NASDAQ:AMGN
170.9B USD 4.8 24.4 17.7 17.7
US
Gilead Sciences Inc
NASDAQ:GILD
148.6B USD 5.1 18.3 12.3 12.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
114.8B USD 9.8 31.2 22.9 23.9
US
Epizyme Inc
F:EPE
94.1B EUR 2 083.7 -531.7 -579 -563.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
78.1B USD 5.5 17.1 16.2 18.4
AU
CSL Ltd
ASX:CSL
86.8B AUD 3.7 19.2 12.9 16.1
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
52.4B USD 16.3 1 202.7 158 191.6
NL
argenx SE
XBRU:ARGX
43B EUR 14 33 56.7 58.2
P/E Multiple
Earnings Growth PEG
US
A
Albireo Pharma Inc
F:BDQM
Average P/E: 189.2
Negative Multiple: -7.7
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -160 693.5 N/A N/A
US
Abbvie Inc
NYSE:ABBV
168.1
89%
1.9
US
Amgen Inc
NASDAQ:AMGN
24.4
45%
0.5
US
Gilead Sciences Inc
NASDAQ:GILD
18.3
190%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
31.2
N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -531.7 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.1
9%
1.9
AU
CSL Ltd
ASX:CSL
19.2
11%
1.7
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
1 202.7
N/A N/A
NL
argenx SE
XBRU:ARGX
33
40%
0.8
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
A
Albireo Pharma Inc
F:BDQM
Average EV/EBITDA: 39.1
Negative Multiple: -6.4
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -195 133.1 N/A N/A
US
Abbvie Inc
NYSE:ABBV
16.3
14%
1.2
US
Amgen Inc
NASDAQ:AMGN
17.7
11%
1.6
US
Gilead Sciences Inc
NASDAQ:GILD
12.3
7%
1.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
22.9
16%
1.4
US
E
Epizyme Inc
F:EPE
Negative Multiple: -579 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.2
11%
1.5
AU
CSL Ltd
ASX:CSL
12.9
8%
1.6
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
158
N/A N/A
NL
argenx SE
XBRU:ARGX
56.7
839%
0.1
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
A
Albireo Pharma Inc
F:BDQM
Average EV/EBIT: 45.2
Negative Multiple: -6.4
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -192 906.4 N/A N/A
US
Abbvie Inc
NYSE:ABBV
23.1
30%
0.8
US
Amgen Inc
NASDAQ:AMGN
17.7
20%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
12.3
12%
1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
23.9
16%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -563.5 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18.4
13%
1.4
AU
CSL Ltd
ASX:CSL
16.1
11%
1.5
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
191.6
N/A N/A
NL
argenx SE
XBRU:ARGX
58.2
N/A N/A